Mercury Poisoning

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Mercury Poisoning trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (4 shown)

UnknownPhase 2/3

NCT04183595

NBMI Treatment in Patients With Mercury Toxicity

NBMI (N1, N3-Bis-(2-Mercaptoethyl) Isophthalamide) is a new metal chelator drug proposed as an alternative to the current chelators, and it is widely different;…

Colombia116 participantsStarted 2023-11-22

Treatment: (N1, N3-bis(2- mercaptoethyl)isophthalamide), Excipients microcrystalline cellulose, silica and magnesium stearate

CompletedPhase 2

NCT02486289

Pilot Proof of Concept Study of NBMI Treatment of Mercury Intoxication

A randomized, placebo controlled, double blind proof of concept study of NBMI in treatment of mercury intoxication.

Ecuador36 participantsStarted 2015-08

Treatment: Emeramide, Placebo

CompletedNot Applicable

NCT00013858

Environmental Contaminants and Infant Development

This study is designed to examine the effects of prenatal exposure to environmental contaminants on cognitive and behavioral development and physical growth in…

Canada280 participantsStarted 1997-01

CompletedNot Applicable

NCT02159235

Heavy Metals, Angiogenesis Factors and Osteopontin in Coronary Artery Disease (CAD)

The present study aims is to investigate: 1. whether patients suffering from acute resp. chronic ischemic heart disease show higher levels for cadmium (Cd), le…

Austria200 participantsStarted 2010-09